© 2022 All rights reserved.
AI Medical Technology AI Medical Technology
  • Home
  • Dermalyser
  • About
  • Research
  • News
Contact Us
AI Medical Technology
Contact Us

matt.poulter@gmail.com

AI Medical Technology nets SEK10.8 million to accelerate Dermalyser AI-driven diagnostic support tool for skin cancer

AI Medical Technology nets SEK10.8 million to accelerate Dermalyser AI-driven diagnostic support tool for skin cancer

24 Jan 2023 6 Minutes
Northern CapSek Ventures takes part in oversubscribed round First prospective clinical trials showing unmatched levels of sensitivity and specificity Funds...
AI Medical Technology Featured in MedTech Strategist

AI Medical Technology Featured in MedTech Strategist

24 Nov 2022 10 Minutes
Learn how we are Driving Fast, Accurate Diagnosis for All Skin Cancers Dermalyser is an easy to use, AI-based and...
AI Medical Technology Receives ISO 13485:2016 Certification

AI Medical Technology Receives ISO 13485:2016 Certification

2 Nov 2022 4 Minutes
Clinical study in Swedish primary care facilities to validate Dermalyser AI-driven decision support tool for diagnosing malignant melanoma progressing well...
Clinical Study Initiated in Primary Care Facilities to Validate Dermalyser

Clinical Study Initiated in Primary Care Facilities to Validate Dermalyser

1 May 2022 5 Minutes
Stockholm, Sweden, May 2, 2022. On the first day of this year’s Skin Cancer Awareness Month, Swedish Artificial Technology start-up...
AI Medical Technology logo colour

Website Privacy Policy

Contact Us

Dermalyser

BSI

+46 721748339
Stockholm, Sweden

© 2022 All rights reserved